Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Pharmacodynamics of CNP During Growth Hormone Treatment
This study is enrolling participants by invitation only.
Study NCT01504802 Information provided by Nemours Children's Clinic
First Received on July 20, 2011. Last Updated on February 13, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pituitary Dwarfism
Idiopathic Short Stature
Additional conditions recognized in this trial
Dwarfism
Dwarfism, Pituitary
More general conditions related to this trial
Bone Diseases
Bone Diseases, Developmental
Bone Diseases, Endocrine
Brain Diseases
Central Nervous System Diseases
Endocrine System Diseases
Genetic Diseases, Inborn
Hypopituitarism
Hypothalamic Diseases
Musculoskeletal Diseases
Nervous System Diseases
Pituitary Diseases
Additional drug interventions recognized in this trial
Hormones
Natriuretic Peptide, C-Type
More general drug interventions related to this trial
Cardiovascular Agents
Hormones, Hormone Substitutes, and Hormone Antagonists
Natriuretic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Nemours Children's Clinic
Children's Hospital Los Angeles
Novo Nordisk
Back to top of Main Content
